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INTRODUCTION
Microglia, the primary immune cells in the central 
nervous system, are highly plastic cells.[1] Under resting 
conditions, microglia have a ramified morphology, 
characterized by small cell bodies and numerous 
long branching processes.[2] The ramified microglia 
continuously scan the environment for danger signals 
associated with pathogens or injury.[2,3] When a danger 
signal is detected microglia undergo a rapid change 
in morphology and function, a process that has been 
termed activation.[4] Microglial activation is classically 
described as a graded process, in which the processes 
retract and thicken, cell body size increases and the 
cell starts excreting cytokines and radical species.[1,4,5] 
Eventually, the microglia may become amoeboid cells 
capable of phagocytosis.[5] More recently, it has become 
apparent that depending on the signal detected and local 
environment microglia can undergo various changes 
in morphology and function.[2,6] Although microglial 
activation provides a defense against injury and 
infection, chronic or excessive activation is considered 
to be detrimental and has been implicated in many 
neurodegenerative and psychiatric disorders.[2,5,7]
Ionized calcium-binding adaptor protein-1 (IBA-1) 
is a 17-kDa actin-binding protein that is specifically 
and constitutively expressed in all microglia.[8,9] It is 
widely employed as an immunohistochemical marker 
for both ramified and activated microglia.[9,10] IBA-1 
is shown to have a function in the actin-crosslinking 
involved in membrane ruffling of microglia.[11] Since 
membrane ruffling is essential for the morphological 
changes from quiescent ramified microglia to activated 
amoeboid microglia, microglial activation is associated 
with increased IBA-1 expression.[8,11] Densitometry 
can, therefore, be utilized for measuring microglial 
activation, especially when microglia is strongly 
activated and/or microglia number is substantially 
increased. However, morphological changes of 
microglia can occur without significantly affecting the 
optical density (OD) in IBA-1 stained brain areas and 
densitometry does not provide any specific information 
on the nature of the morphological changes.
Alternatively, the stadia of microglial activation 
described by Kreutzberg[4] are often used visually 
to determine the activation stage of all individual 
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microglia in an area of interest, and presenting 
activation as the percentage of microglia that score 
above a certain level. This technique provides a 
more specific and sensitive measurement for 
microglia activation than densitometry, but is very 
labor intensive and rather depends on a subjective 
interpretation of the activation stage. Moreover, this 
analysis method is solely based on the classical view 
on microglial activation and as such does not take 
alternatively morphological changes, such as hyper-
ramification into account.[12,13]
In the past years several other methods have been 
developed that involve morphological characteristics, 
such as morphological complexity,[14] the extent of 
ramification[13,15,16] or the length of the dendritic 
processes.[13,15,16] Although these methods allow a 
more detailed and accurate analysis of microglial 
morphology, they still tend to be time consuming and 
depend on specialized equipment (e.g. a confocal 
microscope) and software.
Considering the disadvantages of the aforementioned 
methods, we were in search of a method to determine 
changes in microglial morphology that is quick and easy 
to perform, reproducible, and reliable as a microglial 
activation marker. In this paper, we describe a newly 
developed semi-automatic image analysis method for 
IBA-1 stained brain sections of rat. We compare this 
novel method to the most commonly used methods 
today, namely densitometry and visual characterization 
of the activation stage, using IBA-stained sections of 
rat brains from a previously published experiment.[17]
METHODS
Animals and interventions
To investigate whether our method could be applied to 
rat brain sections with a range of activation stadia we re-
analyzed IBA-1 stained brain sections from a previously 
performed experiment in young and aged rats.[17] Male 
Wistar rats (HsdCpb: WU) of 3 months (young, n = 10) 
and 18-20 months (old, n = 10) were obtained from 
a colony of the Semmelweis University (Budapest, 
Hungary). In each age group, 5 rats were subjected to 
abdominal surgery under anesthesia (3% sevoflurane 
in O2 at 0.7 L/min) and buprenorphine analgesia 
(0.003 mg/kg s.c.) and the other 5 remained naïve as 
control, yielding 4 experimental groups (young control, 
young surgery, old control and old surgery). Between 
week 1 and 6 following surgery, the rats underwent 
several behavioral tests.[17] Animals were sacrificed 
6 weeks after the surgical intervention. All experiments 
were approved by the local animal experiment and 
welfare committee (Dier Experimenten Commissie, 
Groningen, The Netherlands).
Immunohistochemistry
Transcardial perfusion sacrificed animals with saline 
containing 0.1% ethylene diamine tetraacetic acid, under 
pentobarbital anesthesia (6%, 2 mL/kg). Half of each 
brain was immersion fixed in 4% paraformaldehyde for 
4 days followed by cryoprotection with 30% sucrose in 
0.01 mol/L phosphate-buffered saline (PBS). Free floating 
sections of 30 µm containing the prefrontal cortex (PFC) 
and the dorsal hippocampus were pretreated with 0.3% 
H2O2 for 20 min. Sections were incubated for 3 days 
with 1:2500 rabbit-anti IBA-1 (Wako, Neuss, Germany) 
in 2% bovine serum albumin, 0.1% triton X-100 at 4°C, 
followed by a 1 h incubation with 1:500 goat-anti rabbit 
secondary antibody (Jackson, Wet Grove, USA) at room 
temperature. The sections were then incubated for 2 h 
with avidin-biotin peroxidase complex (Vectastain ABC 
kit, Vector, Burlingame, USA) at room temperature. 
Labeling was visualized by using a 0.075 mg/mL 
diaminobenzidine (DAB) solution activated with 0.1% 
H2O2. All dilutions were made in 0.01 mol/L PBS. All 
sections were thoroughly rinsed 4 times with 0.01 
mol/L PBS between staining steps. Sections were 
mounted onto glass slides in a 1% gelatin solution 
and dehydrated through gradients of ethanol and xylol 
solutions.
Analysis of microglial activation
Three immunohistochemical labeled sections per area 
for each rat were analyzed by an operator blinded 
to the treatment. Average microglial activation was 
determined in the apical dendritic field (stratum 
radiatum) of the dentate gyrus inner blade (DGib) and 
the cornu ammonis 1 (CA1) hippocampal region and 
in layer III of the PFC (Zilles’s Cg1).
Densitometry
The OD of the IBA-1 stained sections was measured 
using quantitative imaging software (Leica QWin, Leica 
Microsystems, Rijswijk, The Netherlands), at ×100 
magnification. The OD was corrected according to the 
background staining measured in the corpus callosum 
of each individual section. The resulting average OD in 
each brain area was taken as a measure for microglial 
activation.
Visual characterization
Images were taken of the DGib, CA1 and PFC of 
the IBA-1 stained sections at ×400 magnification 
using quantitative imaging software (Leica QWin, 
Leica Microsystems). In each image, a circle was 
drawn which covered 0.06 mm2 of the original 
section. The microglia in this area were counted and 
morphologically characterized based on the activation 
stages 1-2 or 3-5 as described by Kreutzberg.[4] 
Microglia characterized as being in stages 3-5 were 
considered to be activated. The number of activated 
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microglia expressed as a percentage of the total 
number of microglia was used as a measure for 
microglial activation.
Quantifying morphological characteristics (cell size, cell 
body size, size dendritic processes and cell body size to cell 
size ratio)
As described in the previous section, images were taken 
of the DGib, CA1 and PFC of the IBA-1 stained sections. 
Several morphological characteristics of the stained 
microglia were analyzed by using image analysis 
software (Image-Pro Plus 6.0.0.26, Media Cybernetics, 
Inc. Rockville, USA). Figure 1 shows an overview of the 
method in microglia with a more quiescent morphology 
and microglia with a more activated morphology (for 
clarity purposes only a small section of the original 
picture are shown).
The area of interest was selected. The image analysis 
software automatically analyzes the picture and bases 
on the color intensity and distribution determines the 
background and intensity range of this area. The total 
cell size of all microglia in the area of interest was 
determined by counting all pixels that were darker 
than the background using the “automatic dark objects” 
function. The total cell body size was determined 
by applying an intensity threshold (histogram based 
manual intensity range selection) and size filter 
(area filter range) (similar to the method described by 
Tynan et al.[18]). With the intensity threshold only pixels 
with a staining intensity above a certain value in the 
intensity range scales, (0-255) are counted. Since IBA-
1 staining gives a higher staining intensity in the cell 
bodies than most of the dendritic processes applying 
an intensity threshold will filter out most dendritic 
processes from the analysis. In addition, the size filter 
excludes all pixel clusters that are smaller than a 
certain size from the analysis, filtering out any dendritic 
processes with a high-staining intensity. The intensity 
threshold and size filter depend on the overall intensity 
of the staining. In our case, the intensity threshold was 
150-170 and the size filter was 100 pixels.
In addition, the number of cell bodies was counted to 
give the number of microglia in the area of interest. The 
total size of the dendritic processes was determined 
by subtracting the cell body size from the cell size. 
The total cell size, total cell body size and total size of 
dendritic processes were corrected for the number of 
microglia in the sample area to gain the average size, 
cell body size and size of dendritic processes for each 
microglial cell in the sample. Finally, the cell body to 
cell size ratio (%) was determined and utilized as a 
measurement for microglial activation.
As an alternative to the analysis with Image-Pro 
(Image-Pro Plus 6.0.0.26, Media Cybernetics, Inc.), 
we performed a similar analysis by using ImageJ 
(ImageJ 1.48v, http://imagej.nih.gov/ij), a publically 
available image analysis package. The area of interest 
was selected. Using the adjusted threshold and 
analyze particles functions the intensity thresholds 
and size filter were applied. To measure the total cell 
size the threshold was maintained at the level that 
was automatically provided by the program, and no 
size filter was applied. To measure the total cell body 
size the threshold was lowered 40 points, and size filter 
of 150 pixels was applied.
Figure 1: Illustration of the image analysis method used to quantify the morphological characteristics of microglia in ionized calcium‑binding adaptor protein‑1 
stained sections (for clarity purposes only a small section of the original picture is shown). Left: the unprocessed pictures. Middle: all the pixels that are darker than 
the background are traced (red lines) to determine the total cell size of all microglia combined. Right: pixel‑clusters that are above an applied staining threshold and 
size-filter are traced (red lines) to determine the total cell body size of all microglia combined, as well as the number of microglia
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Statistical analysis
All statistical analyses were performed using SPSS (IBM 
SPSS Statistics for Windows, 20.0.0.2, New York, USA). 
Means and confidence intervals are shown. Figures 
were prepared by using GraphPad Prism (version 5.00 
for Windows, GraphPad Software, San Diego, 
California, USA). Pearson’s correlation coefficients 
were determined to examine the relationship between 
the various measures for microglial activation for all 
individual brain areas, and all brain areas combined. 
The significance level for the Pearson’s correlation 
coefficients was corrected by using Bonferonni method.
In addition, group comparisons were made for microglial 
activation in the CA1, DGib and PFC combined, using 
an analysis of variance with the experimental group 
as between subject factor followed by Tukey post-hoc 
analysis. Outcomes were considered to be significant 
when P < 0.05.
RESULTS
Table 1 shows the average values of the outcome 
measures used to analyze microglia activation.
The image analysis by Image-Pro and ImageJ yielded 
highly comparable results as indicated by a strong 
correlation of the main outcome parameters cell 
body size (r = 0.792, P = 0.000), size of dendritic 
processes (r = 0.499, P = 0.029) and cell body to cell 
size ratio (r = 0.918, P = 0.000). Therefore, we have 
only used the outcomes of the analysis with Image-Pro 
for the rest of the study.
There is no significant correlation between OD and 
the other parameters used to measure microglia 
activation. The Pearson’s correlations between the 
percentages of activated microglia based on visual 
characterization and the quantified morphological 
characteristics are shown in Table 2. In all separate 
brain area, the parameter of the cell body to cell size 
ratio is significantly and strongly correlated with 
microglial activation based on visual characterization. 
Therefore, this outcome may be a more accurate 
morphological characteristic to represent a marker 
of (classical) microglial activation.
Figure 2 shows a scatter plot of microglia activation 
based on morphological characterization and the cell 
body to cell size ratio for the three analyzed brain areas 
combined.
A comparison of the study outcome using the different 
analysis techniques is presented in Figure 3, which 
displays the average of densitometry measurements 
[Figure 3a], visual characterization [Figure 3b] 
and our novel measurement, cell body to cell size 
ratio [Figure 3c]. Whereas the OD does not differ 
significantly between experimental groups, both the 
percentages of activated microglia based on visual 
characterization and the cell body to cell size ratio 
shows a significant difference between groups (visual 
Table 1: Outcome measures microglial analysis
n Mean (95% CI)
Activated microglia (stages 3‑5) (%) 60 40.4 (37.0‑43.9)
Optical density 60 0.17 (0.16‑0.18)
Number of microglia 60 13.3 (12.7‑13.8)
Average cell size (pixels) 59 2341 (2227‑2454)
Average cell body size (pixels) 59 328 (302‑355)
Average size dendritic processes (pixels) 59 2013 (1910‑2116)
Cell body to cell size ratio (%) 60 14.2 (13.2‑15.1)
Mean ± SEM of the outcome measures used to analyze microglial activation. Average 
outcomes are representing an area of 0.06 mm × 0.06 mm in the CA1, dentate gyrus 
inner blade and prefrontal cortex. The visual characterization outcomes and number of 
microglia have been previously published by Hovens et al.[17] CA1: cornu ammonis 1; CI: 
confidence interval, SEM: standard error of the mean
Table 2: Correlation between the percentages of 

















DGib 0.137 0‑0.449 0.625# 0‑0.495 0.839*
CA1 0.001 0‑0.282 0.796* 0‑0.524 0.890*
PFC 0‑0.390 0‑0.029 0.680* 0‑0.288 0.944*
Total 0‑0.104 0‑0.170 0.619* 0‑0.343# 0.855*
Correlation (Pearson’s R) between the percentage of activated microglia as 
determined by visual characterization according to Kreutzberg and the quantified 
morphological characteristics of microglia in the DGib (n = 20), hippocampal CA1 
region (n = 20), PFC (n = 20) and all three brain areas combined (total, 
n = 60). The morphological characteristics are: the number of microglia (number 
of cells), the average size of microglia (cell size), the average cell body size 
of microglia (cell body size), the average size of the dendritic processes of 
microglia (processes size) and the cell body to cell size ratio (cell body/cell) in 
the area of interest. *P < 0.0013, #P = 0.01. PFC: prefrontal cortex; CA1: cornu 
ammonis 1; PFC: prefrontal cortex; DGib: dentate gyrus inner blade
Figure 2: Relation of the cell body tot cell size ratio (cell body size as percentage 
of total cell size) with the percentage of activated microglia (activation 
stages 3‑5) based on visual characterization for all rats in all analyzed brain 
areas. A regression line with associated Pearson’s r is shown
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characterization: F3,56 = 23.86, P = 0.000; cell body 
to cell size ration: F3,56 = 22.48, P = 0.000). Both 
of these measures for microglial activation show a 
similar pattern, with both groups of old rats showing 
increased microglial activation when compared to 
their young counterparts and further increase of 
microglial activation observed only in operated old 
rats.
Additional morphological characteristics of microglia 
in the IBA-1 stained sections are presented in Figure 4. 
Total cell size [Figure 4a] does not differ significantly 
among groups (F3,56 = 1.88, P = 0.144). The total cell 
body size [Figure 4b] differs significantly among 
groups (F3,56 = 5.66, P = 0.002), with a significant 
increase in cell body size only in old rats after surgery. 
The total size of the dendritic processes [Figure 4c] 
differs significantly among groups (F3,56 = 4.33, 
P = 0.008) with a significant decrease in the size of 
dendritic processes only in old rats compared to their 
young counterparts; however no effect of surgery was 
observed.
The number of cell bodies in the areas of interest did not 
differ significantly in our experiment (young control: 
14.0 [12.6-15.3]; young surgery: 13.9 [12.3-15.5]; old 
control: 12.5 [11.7-13.3]; old surgery: 12.8 [12.0-13.6]; 
F3,56 = 0.89, P = 0.454).
DISCUSSION
The aim of the current study was to validate a newly 
developed semi-automatic image analysis method 
to analyze microglial morphology as marker for 
microglia activation in IBA-1 stained brain sections 
of rat. For this purpose, we adapted a method 
previously developed by Vinet et al.,[10] using image 
analysis with an intensity threshold and size filter, 
to obtain the cell body size and the total cell size of 
microglia. We used these parameters as a measure 
for morphological changes and presented cell body 
to cell size ratio as validated measure of microglial 
activation.
In this study, we compare different analysis methods 
for IBA-1 stained brain sections of young and aged rats 
with or without surgery.[17] Surgery has been associated 
with the development of postoperative cognitive 
dysfunction (POCD), including impairment of memory, 
attention, and executive functions.[19-22] Accumulating 
evidence indicates that surgery-induced (neuro) 
inflammation plays an important role in POCD 
development.[19,20,22-25] Although patients of all ages can 
experience POCD, persisting and more severe problems 
are mainly seen in elderly surgical patients.[22,26] Aging 
itself is also associated with neuroinflammatory 
changes in several brain regions, which may contribute to 
the increased incidence of POCD in elderly patients.[1,19,27] 
Hence, our study design allows us to investigate whether 
different analysis methods can distinguish the effects 
of an intervention associated with pathophysiological 
changes, and the effects of aging, which could be 
considered to be a more physiological process.
The cell body to cell size ratio shows a very strong 
positive correlation with microglial activation 
determined by the visual characterization method. 
Both visual characterization and the newly developed 
method reveal similar alterations related to aging 
and surgery, validating the cell body to cell size 
ratio as a marker for (classical) microglial activation. 
However, no correlation was observed with 
densitometry, nor did densitometry measurements 
distinguish microglial changes related to aging and 
surgery could be obtained. Seemingly densitometry 
may have insufficient sensitivity to distinguish the 
relatively modest changes in IBA-1 protein expression 
that accompanies the microglial activity associated 
with aging and surgery.[19,20,23] In addition, our new 
method provides outcome parameters that can be 
used for a more detailed analysis of microglia in an 
area of interest. Firstly, changes in the number of 
microglia can be determined. Second, by studying 
Figure 3: Potential markers for microglial activation in young and old rats with 
or without surgery. (a) The corrected optical density as marker for microglia 
activation; (b) The percentage of activated microglia (with an activation 
stage ≥ 3) based on visual characterization. (c) The cell body to cell size ratio (%) 
as marker for microglia activation. YC: young control; YS: young surgery; OC: 
old control; OS: old surgery. **P < 0.01 and ***P < 0.001 compared to young 
rats. +P < 0.05 and ++P < 0.01 compared to age matched controls
cba
Figure 4: Morphological characteristics of microglia in young and old rats with 
or without surgery. (a) The total cell size (pixels) in the area of interest; (b) The 
total cell body size (pixels) in the area of interest; (c) The total size of the dendritic 
processes (pixels) in the area of interest. YC: young control; YS: young surgery; 
OC: old control; OS: old surgery. *P < 0.05 and **P < 0.01 compared to young rats
cba
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the total microglial cell size, cell body size and size 
of the dendritic processes separately, the specific 
characteristics of the morphological changes can be 
investigated. In our experiment for instance, it became 
apparent that (without significantly changing the 
number of microglia or cell size) there is a reduction of 
the size of the dendritic processes. Surgery, on the other 
hand, led to increased cell body size, specifically in 
the aged rats. Accordingly, a dystrophic deramificated 
morphology of microglia has been observed in old rats 
and humans,[6,28] whereas surgery was associated with 
a more classical microglial activation.[20,29]
The method proposed in this article has several 
limitations. Firstly, in this study we validated our 
method on relatively small areas (0.06 mm2) in order 
to compare it to microglial activation based on visual 
characterization in those same areas. Therefore, only 
approximately 13 microglia/area were analyzed. 
However, we successfully explored the method on 
substantially larger areas (data not shown), further 
confirming its benefits.
Second, although we aim for an objective marker 
for microglial activation, the staining threshold and 
size filter have to be subjectively determined by 
researchers based on the staining intensity of the 
dendritic processes and cell bodies. A possible solution 
is to standardize the value of the intensity threshold as 
compared to the intensity threshold of the background 
(provided by the program).
Third, the outcome of the analysis is largely dependent 
on the quality of the staining. Currently, we do not 
have a method automatically to filter out artifacts. To 
circumvent this problem, it is possible to analyze only 
those sections with good quality by manually indicating 
the area of interest. However, this makes the analysis 
more time consuming and may lead to bias.
We developed this method to analyze IBA-1 stained 
microglia in DAB stained sections. Theoretically the 
analysis could be applied to fluorescent staining. 
However, the analysis depends substantially on a 
clear visibility of the dendritic processes and with 
fluorescent staining this is not always the case. If 
dendrites are not clearly visible, only the cell body size 
could be measured as an alternative to our method.
Finally, in this study we only looked at age-related 
and surgery-induced microglial activation. Microglial 
activation in these cases is expected to be relatively 
subtle. Therefore, we currently cannot confirm whether 
our method is applicable for other conditions in which 
microglia activation occurs, such as the most extensive 
neuroinflammation in brain trauma.
In conclusion, the method for analyzing microglial 
morphological changes as marker for microglial 
activation by semi-automatic image analysis of IBA-1 
stained brain sections, described in this article, provides 
a novel sensitive marker for microglial activation in 
rats, which is quick and easy to perform and provides 
additional information about the morphological 
characteristics of microglia. Although conclusions 
about microglial activation based on morphological 
characteristics alone should be drawn with great 
caution, this novel analysis method could, combined 
with other markers related to microglial activation, 
contribute to research in the field of neuroimmunology.
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